We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.75B
AUM Growth
+$188M
Cap. Flow
+$19.8M
Cap. Flow %
0.72%
Top 10 Hldgs %
19.69%
Holding
327
New
32
Increased
100
Reduced
149
Closed
29

Sector Composition

Rank Sector Weight
1 Healthcare 22.97%
2 Industrials 19.87%
3 Technology 17.13%
4 Consumer Discretionary 9.66%
5 Communication Services 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTEK icon
1
Tetra Tech
TTEK
$8.47B
$66.9M 2.43%
5,721,380
-548,600
-9% -$5.86M
SFLY
2
DELISTED
Shutterfly, Inc.
SFLY
$65.3M 2.37%
725,051
-89,581
-11% -$8.04M
PINC
3
DELISTED
Premier
PINC
$60.1M 2.18%
1,650,914
+403,295
+32% +$13.4M
EBS icon
4
Emergent Biosolutions
EBS
$370M
$57.6M 2.09%
1,141,021
+174,614
+18% +$9.1M
LGND icon
5
Ligand Pharmaceuticals
LGND
$5.83B
$55.3M 2.01%
427,873
-60,548
-12% -$6.76M
PLAY icon
6
Dave & Buster's
PLAY
$376M
$53.4M 1.94%
1,121,920
+60,635
+6% +$2.68M
SUPN icon
7
Supernus Pharmaceuticals
SUPN
$2.59B
$48M 1.75%
802,661
-499,067
-38% -$25.9M
POOL icon
8
Pool Corp
POOL
$6.75B
$46.4M 1.69%
306,241
-26,985
-8% -$3.96M
STRA icon
9
Strategic Education
STRA
$1.87B
$44.3M 1.61%
391,857
+47,798
+14% +$5.11M
STMP
10
DELISTED
Stamps.com, Inc.
STMP
$44.2M 1.61%
174,751
-72,280
-29% -$17.4M
IDTI
11
DELISTED
Integrated Device Technology I
IDTI
$44.2M 1.61%
1,385,843
-117,994
-8% -$3.75M
SMTC icon
12
Semtech
SMTC
$11.2B
$39.8M 1.45%
845,027
+42,916
+5% +$1.92M
ZD icon
13
Ziff Davis
ZD
$1.94B
$35.9M 1.31%
476,559
+16,959
+4% +$1.24M
AX icon
14
Axos Financial
AX
$5.71B
$35.8M 1.3%
875,365
-3,139
-0.4% -$130K
MTN icon
15
Vail Resorts
MTN
$5.35B
$34.4M 1.25%
125,282
+6,731
+6% +$1.65M
DOOR
16
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$34M 1.24%
473,706
+119,195
+34% +$7.81M
TFX icon
17
Teleflex
TFX
$5.89B
$33.5M 1.22%
124,775
-11,011
-8% -$2.95M
WNS
18
DELISTED
WNS Holdings
WNS
$33.2M 1.21%
636,267
+12,437
+2% +$614K
LCII icon
19
LCI Industries
LCII
$2.49B
$33M 1.2%
366,262
+11,195
+3% +$1.04M
CRTO icon
20
Criteo S.A. Ordinary Shares
CRTO
$1.08B
$33M 1.2%
1,004,420
+34,781
+4% +$958K
CMPR icon
21
Cimpress
CMPR
$2.34B
$32M 1.16%
220,799
+8,700
+4% +$1.26M
BEAT
22
DELISTED
BioTelemetry, Inc.
BEAT
$30.1M 1.09%
669,076
-29,299
-4% -$1.17M
OZK icon
23
Bank OZK
OZK
$5.59B
$29.4M 1.07%
651,828
+34,555
+6% +$1.65M
CY
24
DELISTED
Cypress Semiconductor
CY
$28.1M 1.02%
1,803,933
+34,865
+2% +$575K
ON icon
25
ON Semiconductor
ON
$32.6B
$27.7M 1.01%
1,245,670
+121,014
+11% +$2.93M

Similar funds

Rice Hall James & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Rice Hall James & Associates held 327 positions worth $2.75B, up 7.3% from $2.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rice Hall James & Associates's Q2 2018 filing shows 32 new, 100 increased, 149 reduced and 29 closed positions. Its largest new stake was DIPLOMAT PHARMACY, INC.: 818,939 shares worth $20.9M. The largest sale was Supernus Pharmaceuticals, an estimated $25.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q2 2018 buy was DIPLOMAT PHARMACY, INC.: 818,939 shares worth $20.9M.
  • Rice Hall James & Associates added most to Apogee Enterprises in Q2 2018, an estimated $15.9M increase.
  • Rice Hall James & Associates's biggest Q2 2018 reduction was Supernus Pharmaceuticals, cutting an estimated $25.9M.
  • Rice Hall James & Associates fully exited Viasat in Q2 2018, selling an estimated $17M.
  • Rice Hall James & Associates's ten largest holdings make up 20% of its $2.75B portfolio in Q2 2018.
  • Rice Hall James & Associates opened 32 new positions and closed 29 in Q2 2018.
  • Rice Hall James & Associates's portfolio value rose 7.3% quarter-over-quarter to $2.75B.

Based on Rice Hall James & Associates's 13F filing for Q2 2018, filed 2 Aug 2018.